2. DIABETES
It is a GROUP of metabolic
disease characterised by
chronic hyperglycemia with
DISTURBANCE in the
carbohydrate, fat & protein
metabolism resulting from
DEFECTS in insulin
secretion, insulin action or
both .
3. Pancreas beta cells
Insulin actions
Glucose
entry and
utilization
(oxidation,
storage)
Glucose
entry and
oxidation
TG synthesis
Normal glucose and fat metabolism
4. Pancreas beta cells
Insulin actions
Glucose
entry and
utilization
(oxidation,
storage)
Glucose
entry and
oxidation
TG synthesis
Metabolic consequences of insulin deficiency/resistance
5. Clinical Features of DM due to insulin lack
Polyphagia
(decr. leptin?)
Starvation in the
midst of plenty
Hyperosmolar
hyperglycemic
syndrome (HHS)
Lactic
acidosis
Lactic
acidosis
Muscle protein breakdown
Acetoacetate,0H-butyrate, acetone
6.
7. ⢠Insulin level increases when?
a) Glucose administered by mouth (food intake)
b) Glucose given by IV (glucose infusion)
c) No difference
10. DIABETIC KETOACIDOSIS
⢠It is a MEDICAL emergency
⢠PRINCIPALLY seen in type 1 diabetes
⢠Mortality-
⢠CHILDREN & ADOLESCENTS- cerebral edema
⢠ADULTS- hypokalemia, acute respiratory distress syndrome
& co-morbid conditions
21. ⢠It is characterised by
1) SEVERE hyperglycaemia (>600mg/dL)
2) Hyperosmolality (serum osmolality >320 mOsm/kg)
3) Dehydration (in the ABSENCE of significant hyperketonemia or
acidosis)
22. ď CLINICAL MANIFESTATIONS
⢠Polyuria, weight loss, and diminished oral intake
⢠Profound dehydration
⢠Hypotension, tachycardia and altered mental status
⢠Mental confusion, lethargy or coma
24. HYPOGLYCEMIA
⢠Hypoglycemia (<63mg/dL) in DIABETES occurs due to insulin
overdose or hyperinsulinemia
⢠Whippleâs triad-
a) Symptoms consistent with HYPOGLYCEMIA
b) Low plasma glucose conc. (measured with a precise method)
c) Relief of symptoms after plasma glucose level is RAISED
25. Causes of Hypoglycemia in patients taking insulin
ďMissed, delayed or inadequate meal
ďUnexpected or unusual exercise
ďAlcohol
ďErrors in oral anti-diabetics or insulin
dose/schedule/administration
ďPoorly designed insulin regimen
ďLipoatrophy at injection sites
ďFactitous (deliberately induced)
ďBreasting feeding by DIABETIC mother
26. NORMAL
When blood glucose level FALLS
Endogenous insulin
release is SUPRESSED
Release of
glucagon is
INCREASED
Autonomic nervous
system is ACTIVATED
Release of catecholamine;
stress hormones are
INCREASED in blood
REDUCTION of whole blood
glucose uptake & INCREASES
hepatic glucose production
Thus, maintaining glucose supply to brain
29. ď MANAGEMENT
MILD (self treated)
⢠Oral fast acting carbohydrate (10-15g) is taken as glucose drink
or tablets or confectionery
⢠Followed with a snack containing complex carbohydrate
SEVERE
⢠If patient is SEMI-CONSCIOUS OR UNCONSCIOUS-
oIV 75mL 20% dextrose (0.2g/kg in children) OR IM glucagon
(0.5mg in children)
⢠If patient is CONSCIOUS and able to SWALLOW-
oGive oral refined glucose as drink or sweets (25mg)
30. Dawn phenomenon & Somogyi effect
⢠DAWN PHENOMENON occurs when endogenous insulin
secretion decreases
⢠SOMOGYI EFFECT is seen in cases of excessive amounts of
exogenous insulin
31. SOMOGYI EFFECT
TOO MUCH INSULIN
HYPOGLYCEMIA
GLUCAGON IS RELEASED
LIPOLYSIS
GLUCONEOGENESIS
GLYCOGENOLYSIS
REBOUND
HYPERGLYCEMIA
+
KETOSIS
32. DAWN PHENOMENON
Bodyâs response to hormones released in
early morning hours
Counter-regulatory hormones are released
Glucose level increases
In DM, there is decrease in insulin levels
So HIGH GLUCOSE levels in morning
33.
34. DKA vs. HHS
HHSDKA
More in elderlyMore in childrenAge
More in type IIMore in type IDM type
> 600> 250Glucose
+ or -+++++Ketonuria/emia
>7.3<7.3pH
>15<15HCO3
HyperosmolarityVariableS osmolarity
Sensitive to small doseVariableSensitivity to insulin
35. DKA vs. HYPOGLYCEMIA
HypoglycemiaDKA
Insulin overdose or
hyperinsulinemia
Insulin deficiency or increased
counter-reg hormones
Etiology
AcuteGradualOnset
-S of Brain glucopenia
- S of sympathetic overactivity
S of hyperglycemia
S of dehydration
S of acidosis
Symptoms and signs
hypoglycemiahyperglycemiaRBS
NoYesKetonuria
NoYesKetonemia
Rapidly recover if earlyNo effectIV glucose
Hinweis der Redaktion
Balanitis â candadiasis;
Following food intake, a number of other factors {amino acids(food contains fats, proteins, carbohydrates), hormones(glucagon like peptide 1 & gastrointestinal peptide)} released from the gut following food intake can increase the insulin release-known as incretin effect
Incretin effect pic
These are effective in incretin based therapies
Mortality is high in developing countries and among non-hospitalised patients
Co-morbid conditions- acute MI, sepsis or pneumonia
Insulin deficiency is RELATIVE or ABSOLUTE
1) Electrolyte loss mostly Na & K-causes hyperaldosteronism
3) Elevated catecholamines & other stress hormones cause lipolysis
-when hepatic ketogenesis exceeds in the body, acidic ketones accumulate in blood(metabolic acidosis)